(Q24247344)

https://api.crossref.org/works/10.1002%2F14651858.CD004815

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

Unstable Angina : An Etiologic Approach to Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Verapamil use in patients with cardiovascular disease: an overview of randomized trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Effects of early and late administration of angiotensin-converting enzyme inhibitors on mortality after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Platelet GPIIb-IIIa blockers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Improving outcome over time of percutaneous coronary interventions in unstable angina

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice g

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

A randomized study comparing propranolol and diltiazem in the treatment of unstable angina

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Coronary arteriographic findings soon after non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Aspirin, heparin, or both to treat acute unstable angina

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004815

7 January 2021